Precision Assays. Complex Synthesis.
Accelerate lead selection with high analytical certainty. We integrate advanced biology assays and specialised synthetic chemistry to deliver robust, reproducible data directly to your ELN.
Integrated Assay Platforms
From high-resolution molecular analysis to high-throughput screening, our dual-corridor laboratories operate under strict analytical protocols to validate target engagement.
Target Validation
Complex Chemistry
Deploy advanced biophysical and cellular assays to quantify molecular interactions. We run high-content imaging, NanoBRET, CRISPR editing, and surface plasmon resonance (SPR) for real-time kinetic profiling.
Access specialised synthetic routes for challenging modalities. Our chemists design and scale complex molecules, delivering high-purity compounds with complete analytical validation.
Our protocols cover complete cellular target engagement, phenotypic screening, and functional validation across diverse disease models.
We specialise in the synthesis of PROTACs, custom peptides, stable isotopes, and highly regulated nitrosamine impurities.
Integrated DMPK Screening
Optimise lead candidates early with robust ADME profiling. We combine automated screening with high-resolution mass spectrometry to deliver clear, actionable pharmacokinetic profiles.
In Vitro ADME
Analytical Suite
Data Integration
Our standard screens measure metabolic stability in microsomes and hepatocytes, alongside CYP inhibition, plasma protein binding, and PAMPA permeability.
Our state-of-the-art laboratory is fully equipped with 400 MHz NMR, Prep-HPLC, and LC-MS/MS systems to provide absolute structural confirmation.
Collaborators gain direct, secure Web ELN access with real-time project tracking and downloadable raw analytical data for complete compliance.